Roberto M Saraiva1, Joshua M Hare. 1. Cardiology Division, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: The role played by nitric oxide (NO) in cardiovascular physiology remains highly controversial. Following the discovery that NO is the prototypic endothelium-derived relaxing factor, this signaling molecule was implicated as possessing many other biological actions within the cardiovascular system, including effects on cardiac contraction, relaxation, and energetics. Here, we discuss new concepts regarding NO signaling, its effector pathways, and interactions between NO and the redox milieu within a framework of cardiac physiology and pathophysiology. RECENT FINDINGS: Major recent insights that have advanced understanding of the mechanisms of NO bioactivity include the following. (1) NO acts in subcellular signaling compartments or modules. (2) S-nitrosylation (covalent modification of cysteine thiol moieties) of proteins represents a prototypic second messenger signaling mode in biologic systems. (3) Reactive oxygen and nitrogen species work together to facilitate signaling. (4) Disruption of physiologic signaling can occur by either increased formation of reactive oxygen species or decreased production of reactive nitrogen species, a situation of nitroso-redox imbalance. SUMMARY: These insights, which challenge classically held views that NO acts as a freely diffusible molecule regulated primarily by concentration and exerting signaling primarily through cyclic GMP production, offer a new perspective on the pathophysiology and treatment of congestive heart failure.
PURPOSE OF REVIEW: The role played by nitric oxide (NO) in cardiovascular physiology remains highly controversial. Following the discovery that NO is the prototypic endothelium-derived relaxing factor, this signaling molecule was implicated as possessing many other biological actions within the cardiovascular system, including effects on cardiac contraction, relaxation, and energetics. Here, we discuss new concepts regarding NO signaling, its effector pathways, and interactions between NO and the redox milieu within a framework of cardiac physiology and pathophysiology. RECENT FINDINGS: Major recent insights that have advanced understanding of the mechanisms of NO bioactivity include the following. (1) NO acts in subcellular signaling compartments or modules. (2) S-nitrosylation (covalent modification of cysteine thiol moieties) of proteins represents a prototypic second messenger signaling mode in biologic systems. (3) Reactive oxygen and nitrogen species work together to facilitate signaling. (4) Disruption of physiologic signaling can occur by either increased formation of reactive oxygen species or decreased production of reactive nitrogen species, a situation of nitroso-redox imbalance. SUMMARY: These insights, which challenge classically held views that NO acts as a freely diffusible molecule regulated primarily by concentration and exerting signaling primarily through cyclic GMP production, offer a new perspective on the pathophysiology and treatment of congestive heart failure.
Authors: Kentaro Ozawa; Erin J Whalen; Christopher D Nelson; Yuanyu Mu; Douglas T Hess; Robert J Lefkowitz; Jonathan S Stamler Journal: Mol Cell Date: 2008-08-08 Impact factor: 17.970
Authors: Nora Franceschini; Ervin Fox; Zhaogong Zhang; Todd L Edwards; Michael A Nalls; Yun Ju Sung; Bamidele O Tayo; Yan V Sun; Omri Gottesman; Adebawole Adeyemo; Andrew D Johnson; J Hunter Young; Ken Rice; Qing Duan; Fang Chen; Yun Li; Hua Tang; Myriam Fornage; Keith L Keene; Jeanette S Andrews; Jennifer A Smith; Jessica D Faul; Zhang Guangfa; Wei Guo; Yu Liu; Sarah S Murray; Solomon K Musani; Sathanur Srinivasan; Digna R Velez Edwards; Heming Wang; Lewis C Becker; Pascal Bovet; Murielle Bochud; Ulrich Broeckel; Michel Burnier; Cara Carty; Daniel I Chasman; Georg Ehret; Wei-Min Chen; Guanjie Chen; Wei Chen; Jingzhong Ding; Albert W Dreisbach; Michele K Evans; Xiuqing Guo; Melissa E Garcia; Rich Jensen; Margaux F Keller; Guillaume Lettre; Vaneet Lotay; Lisa W Martin; Jason H Moore; Alanna C Morrison; Thomas H Mosley; Adesola Ogunniyi; Walter Palmas; George Papanicolaou; Alan Penman; Joseph F Polak; Paul M Ridker; Babatunde Salako; Andrew B Singleton; Daniel Shriner; Kent D Taylor; Ramachandran Vasan; Kerri Wiggins; Scott M Williams; Lisa R Yanek; Wei Zhao; Alan B Zonderman; Diane M Becker; Gerald Berenson; Eric Boerwinkle; Erwin Bottinger; Mary Cushman; Charles Eaton; Fredrik Nyberg; Gerardo Heiss; Joel N Hirschhron; Virginia J Howard; Konrad J Karczewsk; Matthew B Lanktree; Kiang Liu; Yongmei Liu; Ruth Loos; Karen Margolis; Michael Snyder; Bruce M Psaty; Nicholas J Schork; David R Weir; Charles N Rotimi; Michele M Sale; Tamara Harris; Sharon L R Kardia; Steven C Hunt; Donna Arnett; Susan Redline; Richard S Cooper; Neil J Risch; D C Rao; Jerome I Rotter; Aravinda Chakravarti; Alex P Reiner; Daniel Levy; Brendan J Keating; Xiaofeng Zhu Journal: Am J Hum Genet Date: 2013-08-22 Impact factor: 11.025
Authors: Tamer M A Mohamed; Delvac Oceandy; Sukhpal Prehar; Nasser Alatwi; Zeinab Hegab; Florence M Baudoin; Adam Pickard; Aly O Zaki; Raja Nadif; Elizabeth J Cartwright; Ludwig Neyses Journal: J Biol Chem Date: 2009-03-10 Impact factor: 5.157